Accolade to Announce Fiscal First Quarter 2022 Financial Results

NEXT STORY
Revive Collaborates With University of Health Sciences Antigua To Pioneer Clinical Research of Psychedelics
PREV STORY
ContraFect Appoints Gary Woodnutt, Ph.D. as Senior Vice President of Translational Sciences and Preclinical Development
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BriaCell Therapeutics Corp. Announces US$27.2 Million Private Placement

author_avatar
NASDAQ Market News

Oxford Immunotec Welcomes Updated CDC Recommendations for Tuberculosis Screening and Testing of Healthcare Personnel

author_avatar
NASDAQ Market News

Everest Medicines Completes Enrollment of Phase 3 Clinical Trial of Xerava™ (eravacycline) for the Treatment of Complicated Intra-Abdominal Infections in China

author_avatar
NASDAQ Market News